MedTrace Logo

Clinical and Neuropsychological Investigations in Batten Disease

NCT01873924 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-09-12

No results posted yet for this study

Summary

This study aims to assess the natural history of Batten disease (Neuronal Ceroid Lipofuscinosis) by obtaining information about the motor, behavioral, and functional capabilities of individuals with Batten disease. This study will also refine and validate the Unified Batten Disease Rating Scale (UBDRS) as a clinical rating instrument for Batten disease.

Conditions

  • Neuronal Ceroid Lipofuscinosis
  • Neuronal Ceroid Lipofuscinosis CLN1
  • Neuronal Ceroid Lipofuscinosis CLN2
  • Neuronal Ceroid Lipofuscinosis CLN3
  • Neuronal Ceroid Lipofuscinosis CLN5
  • Neuronal Ceroid Lipofuscinosis CLN6
  • Neuronal Ceroid Lipofuscinosis CLN7
  • Neuronal Ceroid Lipofuscinosis CLN8
  • Neuronal Ceroid Lipofuscinosis CLN10
  • Batten Disease

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Jonathan W Mink, MD PhD · University of Rochester

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2035-08-31
Completion
2035-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01873924 on ClinicalTrials.gov